Celesio shareholders Haniel and Elliott close to agreeing on McKesson takeover
Celesio shareholders Haniel and Elliott are thought to be close to an agreement in which McKesson would acquire majority control of the German pharmaceutical firm, Boersen-Zeitung reported.
The German-language daily said Haniel is expected to take over the Celesio stake held by the financial investor Elliott and then sell it, together with the German family-owned holding's prior stake, to US suitor McKesson, citing undisclosed sources.
Haniel has a roughly 50% stake in Celesio and Elliott has access to about 30%, according to the newspaper. The report noted that McKesson's potential acquisition of these combined shares would trigger a mandatory takeover offer.
McKesson failed earlier this year in a EUR 6.2bn attempt to take over Celesio.
Source Boersen-Zeitung